Aims and Scope

Molecular Imaging and Radionuclide Therapy (formerly Turkish Journal of Nuclear Medicine), is the official publication of Turkish Society of Nuclear Medicine (TSNM) . MIRT is an open access, scientific, peer-reviewed journal in accordance with independent, unbiased, and double-blinded peer-review principles published three times a year (February, June, October) in English.

MIRT is an independent scientific medical journal that aims to reach all relevant national and international medical institutions and persons in electronic and open access free of charge. It is aimed to publish original articles, case reports and reviews that include the results of studies and research conducted in the field of molecular imaging, multimodality imaging, nuclear medicine, radionuclide therapy, radiopharmacy, medical physics, dosimetry and radiobiology and passed through the peer-review process.

Molecular Imaging and Radionuclide Therapy is indexed in Pubmed, Pubmed Central (PMC), Emerging Sources Citation Index (ESCI), TUBITAK-ULAKBIM, Scopus, Gale/Cengage Learning, EBSCO databases, ProQuest Health & Medical Complete, CINAHLEmbase, J-Gate, IdealOnline, Türkiye Atıf Dizini-Turkiye Citation Index, Turk Medline, Hinari, GOALI, ARDI, OARE, AGORA and CNKI.

The editorial and publication processes of the journal are shaped in accordance with the guidelines of the International Committee of Medical Journal Editors (ICMJE)World Association of Medical Editors (WAME)Council of Science Editors (CSE)Committee on Publication Ethics (COPE), European Association of Science Editors (EASE), and National Information Standards Organization (NISO). The journal conforms with the Principles of Transparency and Best Practice in Scholarly Publishing (

Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

Author(s) and copyright owner(s) grant access to all users for the articles published in the Molecular Imaging and Radionuclide Therapy as free of charge. Articles may be used provided that they are cited.

Open Access Policy is based on rules of Budapest Open Access Initiative (BOAI). By “open access” to [peer-reviewed research literature], we mean its free availability on the public internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from gaining access to the internet itself.

Molecular Imaging and Radionuclide Therapy does not demand any subscription fee, publication fee or similar payment for access to electronic resources. All published content is available online, free of charge at

The Journal is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 (CC BY-NC-ND) International License.

Please contact the publisher (Galenos) for your permission to use requests via [email protected]

Advertising Policy

This journal's advertising sales and editorial processes are separated to ensure editorial independence and reduce the effects of financial interests.

Current or potential sponsors and advertisers do not affect editorial decisions in the journal. Advertisers and sponsors have no control or influence over the results of a user's website searches.

Advertisements should not be deceptive or misleading and must be verifiable. Excessive or exaggerated expressions does not be allowed.

If the text or image contains inappropriate or offensive content or is about personal, racial, ethnic, sexual orientation or religious content, these advertisements are not accepted.

Advertisers are responsible for ensuring that their advertisements comply with applicable laws regarding deceptive and/or offensive content and ethical issues.

Especially drug and medical product advertisements can be presented on the cover pages of the journal, separately from the published scientific content and without page number.

The published advertisements are pointed and distinguishable from the editorial content.

Material Disclaimer

Statements or opinions stated in articles published in the journal do not reflect the views of the editors, editorial board and/or publisher; The editors, editorial board and publisher do not accept any responsibility or liability for such materials. All opinions published in the journal belong to the authors.

The financial expenses of Molecular Imaging and Radionuclide Therapy are covered by Turkish Society of Nuclear Medicine.

Permissions/ Publisher Correspondence Address:

Adress: Molla Gürani mh., Kacamak Sk. No: 21/A 34093 Findikzade, Istanbul, Türkiye
 +90 (212) 621 99 25
 +90 (212) 621 99 27
 [email protected]
Web page: